Development of a Novel IGF2BP1 Inhibitor as Metastasis-Specific Therapeutic Agent. (October 2022) - Singh, A.; Singh, V.; Wallis, N.; Elimelech, O.; Oberman, F.; Ramos, A.; Yisraeli, J.; Spiegelman, V.; Sharma, A.